πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Nektar Therapeutics UK Patents

Full USPTO pharma patent portfolio for Nektar Therapeutics UK β€” grant dates, expiration, and drug cross-links.

Patents
423
Expiring ≀24m
24

Quick answer

Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 9

  1. US 10682418

    Polymer-sunitinib conjugates

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10653689

    Combination-based treatment method

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10646578

    Polymer derivatives having particular atom arrangements

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10525051

    Compositions and methods for achieving sustained therapeutic drug concentrations in a subject

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10485877

    Oligomer-phenothiazine conjugates

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10463659

    Multi-arm polymer prodrugs

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10463744

    Polymer-semaxanib moiety conjugates

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10456476

    Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10434181

    Oligomer-containing benzamide-based compounds

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10421838

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10407416

    Kappa opioid agonists and uses thereof

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10385165

    N-maleimidyl polymer derivatives

    Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10322107

    N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10307416

    Oligomer-opioid agonist conjugates

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10265411

    N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10251881

    Particulate materials

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10251959

    Oligomer-beta blocker conjugates

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10231984

    Oligomer-foscarnet conjugates

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10232042

    Conjugates of an anti-TNF-alpha antibody

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10220020

    Polymer-des-ethyl sunitinib conjugates

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10189859

    Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10188614

    Particulate materials

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10144804

    Method for preparing functionalized polymers from polymer alcohols

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10143690

    Oligomer-opioid agonist conjugates

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10130720

    Composition comprising a polymeric reagent

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10132810

    Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10098865

    Multi-arm polymeric prodrug conjugates of taxane-based compounds

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10092656

    Protease inhibitors having enhanced features

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10081602

    Opioid agonists and uses thereof

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10039737

    Multi-arm polymeric alkanoate conjugates

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10011682

    Method of preparing carboxylic acid functionalized polymers

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10010587

    IL-2RΞ²-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9999657

    Polymer-factor VIII moiety conjugates

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9943605

    Polymer-semaxanib moiety conjugates

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9937266

    Oligomer-containing benzamide-based compounds

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9925182

    Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound

    Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9913913

    Method for preparing a polymeric reagent

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9907855

    N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9908970

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9861705

    Conjugates of an IL-2 moiety and a polymer

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9839695

    Polymer-active agent conjugate

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9828465

    N-maleimidyl polymer derivatives

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9827326

    Polymer-sunitinib conjugates

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9827239

    Oligomer-opioid agonist conjugates

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9815824

    Kappa opioid agonists and uses thereof

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9808533

    Multi-arm polymer prodrugs

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9801873

    Methods for treating humans having brain cancer

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9782488

    Oligomer-beta blocker conjugates

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Nektar Therapeutics UK have?

423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Nektar Therapeutics UK patents expire?

24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.